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Quality of colorectal cancer pathology reports is related to individual patient prognosis and future treatment options. This study
sought to validate the prognostic utility of the Royal College of Pathologists minimum pathology dataset (MPD), regarded as the ‘gold
standard’, within a population. Retrospective study of the survival of 5947 surgically resected colorectal cancer patients for whom an
MPD had been collected. Variables were related to survival. The study population was representative of the Yorkshire colorectal
cancer population. Survival was poorer in older patients and colonic tumours and improved over the study period. Local invasion,
total number of lymph nodes retrieved, nodal stage, extramural vascular invasion, peritoneal involvement, distance of invasion beyond
the muscularis propria, and in rectal cancers, circumferential resection margin involvement and distance to this margin were all
validated as of prognostic significance within a population. Failure to report extramural vascular invasion, peritoneal involvement or
circumferential resection margin status was associated with a worse survival than absence of the factor. All variables within the Royal
College of Pathologists MPD are of prognostic significance. High-quality pathology reports are essential in providing accurate
prognostic information and guiding optimal patient management.
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High quality histopathological reporting is vital in the manage-
ment of colorectal cancer. Assessment of the surgical specimen
determines the stage of disease, the completeness of the surgical
excision and, hence, the prognosis and future treatment options
for the patient. It is crucial, therefore, that pathology reports
contain all the accurate information required to fulfil these
functions.
Many pathological features have been identified as being of
prognostic value and therapeutic significance and, as a conse-
quence, there are numerous guidelines stating which pathological
features should be reported for colorectal cancer (Henson et al,
1994). In 1998 the Royal College of Pathologists synthesised,
through the available literature and expert consensus, the features
they deemed as being most important for determining the
prognosis of colorectal cancer into a minimum pathology dataset
(MPD) (Quirke and Williams, 1998). The document is a proforma
detailing the minimum data items a pathologist should record
when reporting colorectal cancer tumours. Much of the evidence
through which it was formulated, however, originated from small
single-centre studies or specialised trial environments and its
validity has never been tested in a population-based setting.
The Northern and Yorkshire Cancer Registry (NYCRIS), in
collaboration with Yorkshire’s pathologists, first published a
proforma for the pathological reporting of colorectal cancer
resections in 1995 following a decision to standardise the
collection of pathology data for registry use. The NYCRIS
proforma was largely adopted by the Royal College of Pathologists
as their MPD in 1998 and so the Northern and Yorkshire region is
in the unique position of having access to identical data to that on
this MPD from 1995. The NYCRIS proforma includes all MPD
items and a few additional data points. NYCRIS also collects basic
demographic and survival information about all patients diag-
nosed with cancer in the region. It is, therefore, possible to link the
MPD to the survival data and, hence, assess the prognostic ability
of the minimum dataset items. This study sought to determine the
prognostic value of the contents of the Royal College of
Pathologists MPD in a population of 3.6 million.
MATERIALS AND METHODS
All colorectal cancer patients for whom a MPD was completed,
therefore having received a surgical resection of their tumour, and
submitted to NYCRIS between 1995 and 2000 were identified.
Routinely recorded information about these patients’ disease and
its management were then downloaded from the main registry
database and the two datasets merged. Any discrepancies were
resolved by review of the original pathology report. Patients with
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smultiple colorectal cancers were excluded. Cases without an MPD
were also identified and their overall survival compared to exclude
bias due to a failure to return forms.
The survival time for each patient was calculated from date of
surgery to date of death from all causes or when censored (9
February 2006). Kaplan–Meier curves were created to compare
univariate survival and log–rank tests were used to test for
statistical significance. Cox-proportional hazards models were
used to determine the impact of sex and age on the survival
estimates for each prognostic factor.
Variables assessed were extent of local invasion, number of
nodes retrieved, nodal stage, extramural vascular invasion (EMVI)
and peritoneal involvement for all patients and circumferential
margin involvement (CRM) and distance to the CRM for rectal
tumours only. Distance of invasion beyond the muscularis propria
was an additional item included on the Yorkshire form but omitted
from the Royal College MPD and the prognostic significance of this
variable was also investigated to support its inclusion in any future
revision. Tumour grade was not investigated as poor correlation
was found between colorectal cancer and main registry databases
due to changes in the coding system over time, meaning accurate
allocation to present groupings of well, moderate and poor
differentiation was impossible.
RESULTS
Between 1995 and 2000, 5947 colorectal pathology forms were
submitted to NYCRIS. This represents 55.5% of the entire
surgically managed colorectal cancer population in Yorkshire over
Table 1 Characteristics and five-year survival of the study population
Characteristics n % % five-year survival 95% Confidence interval
Cancer site Colon 3537 59.5 45.9 44.2–47.5
Rectosigmoid 710 11.9 50.0 46.3–53.6
Rectal 1700 28.6 53.4 51.0–55.7
Age group o51 357 6.0 64.4 59.2–69.2
51–60 834 14.0 60.1 56.7–63.3
61–70 1665 28.0 55.1 52.7–57.4
71–80 2062 34.7 46.2 44.0–48.3
480 1029 17.3 27.7 25.0–30.5
Year of diagnosis 1995 488 8.21 44.1 39.6–48.4
1996 997 16.8 46.9 43.8–50.0
1997 1099 18.5 47.3 44.3–50.2
1998 1069 18.0 47.2 44.2–50.2
1999 1151 19.4 50.8 47.9–53.7
2000 1143 19.2 51.8 48.9–54.7
pT stage pT1 280 4.7 74.6 69.1–79.3
pT2 832 14.0 70.7 67.5–73.6
pT3 3372 56.7 50.6 48.9–52.2
pT4 1415 23.8 25.1 22.9–27.3
Unknown 48 0.8 58.3 43.2–70.8
Number of nodes examined 0–6 nodes 1792 30.1 45.4 43.1–47.7
7–12 nodes 2218 37.3 47.7 45.6–49.8
412 nodes 1856 31.2 53.0 50.7–55.2
Unknown 81 1.4 38.2 27.8–48.7
pN stage 0 3168 53.3 61.0 59.3–62.7
1 1616 27.2 39.8 37.4–42.2
2 958 16.1 22.2 19.7–24.9
Unknown 205 3.5 46.8 39.9–53.5
Extramural vascular invasion Yes 1061 17.8 25.0 22.4–27.6
No 3139 52.8 57.4 55.7–59.2
Unknown 1747 29.8 46.8 44.4–49.1
Peritoneal involvement Yes 1160 19.5 24.3 21.9–26.8
No 4111 69.1 55.4 53.9–56.9
Unknown 676 11.4 48.1 44.3–51.8
Tumour perforation (pT4 tumours only) Yes 167 11.8 26.4 19.9–33.2
No 198 14.0 32.3 26.0–38.9
Unknown 1050 74.2 23.5 21.0–26.1
Distance of invasion beyond the muscularis propria (pT3 tumours only)(mm) 0–1 688 20.4 60.8 57.0–64.3
1.1–5 1086 32.2 54.2 51.2–57.2
5.1–10 470 13.9 43.0 38.5–47.4
10.1–15 205 6.1 39.0 32.4–45.6
415 214 6.4 36.9 30.5–43.4
Unknown 709 21.0 47.5 43.8–51.2
CRM status (rectal tumours only) Involved 260 15.3 26.9 21.7–32.4
Clear 1203 70.8 59.2 56.4–61.9
Not reported 237 13.9 52.7 46.2–58.9
Distance to CRM (rectal tumours only)(mm) p1 216 17.2 33.3 27.1–39.6
1.1–2 149 11.9 52.4 44.0–60.0
2.1–3 118 9.4 56.8 47.4–65.1
3.1–4 97 7.7 51.6 41.2–60.9
4.1–5 97 7.7 60.8 50.4–69.7
5.1–10 270 21.5 58.2 52.0–63.8
410 308 24.5 64.3 58.7–69.4
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sthat time period. There was no significant difference between the
observed five-year survival of our study population (48.5%: 95% CI
47.2–49.8%) and the entire Yorkshire cohort of surgically treated
colorectal cancer patients identified within the main cancer
registry database (46.7%: 95% CI 45.8–47.6%).
The characteristics and five-year survival of our study popula-
tion is presented in Table 1. There was a significant difference in
survival observed across cancer sites, with colon cancers having a
survival of 45.9% (95% CI 44.2–47.5%) and rectal cancers 53.4%
(95% CI 51.0–55.7%). Survival was poorer in the older age groups
and improved over the study period from 44.1% (95% CI 39.6–
48.4%) in 1995 to 51.8% (95% CI 48.9–54.7%) in 2000.
Local invasion
Figure 1 shows the five-year survival curves of patients in each of
the pathological T stages. Patients with T1 (74.6%: 95% CI 69.1–
79.3%) and T2 tumours (70.7%: 95% CI 67.5–73.6%) had
significantly better survival than those with T3 (50.6%: 95% CI
48.9–52.2%) or T4 tumours (25.1%: 95% CI 22.9–27.3%). Patients
in whom the extent of local invasion was not recorded had an
intermediate five-year survival of 58.3% (95% CI 43.2–70.8%). The
effect remained after adjustment for patient age and gender
(Table 2).
Total number of lymph nodes retrieved
Patients from whom greater than 12 nodes were retrieved had
significantly higher survival (53.0%: 95% CI 50.7–55.2%) com-
pared to those with the lowest nodal yield (45.4%: 95% CI 43.1–
47.7%) (Po0.01). Patients in whom the number of nodes retrieved
failed to be reported, had the worst survival (38.2%: 95% CI 27.8–
48.7%). Age and gender did not influence the results (Table 2)
N stage
The greater the number of positive nodes identified the worse
the survival of the patients (Figure 2). Those falling into the N2
category (i.e., four or more positive nodes identified) had the
lowest five-year survival (22.2%: 95% CI 19.7–24.9%) compared to
those with one to three (39.8%: 95% CI 37.4–42.2%) or those who
were node negative (61.0%: 95% CI 59.3–62.7%). Those patients in
whom the number of positive nodes was not reported had an
intermediate five-year survival of 46.8% (95% CI 39.9–53.5%). The
effects remained statistically significant after adjusting for age and
gender (Table 2).
Extramural vascular invasion
Figure 3 shows the presence of EMVI was also prognostic. Patients
in who vascular invasion was present had a poorer five-year
survival (25.0%: 95% CI 22.4–27.6%) than those in whom it was
absent (57.4%: 95% CI 55.7–59.2%). Again, those in whom the
feature was not reported had an intermediate survival between
the two reported groups of 46.8% (95% CI 44.4–49.1%) and
adjustment for age and gender did not influence the results
(Table 2).
Peritoneal involvement
A very similar effect, presented in Figure 4, was observed in
relation to peritoneal involvement. Those possessing peritoneal
involvement had a five-year survival of 24.3% (95% CI 21.9–
26.8%) compared to 55.4% (95% CI 53.9–56.9%) in those in whom
it was absent. Patients for whom the factor was not reported again
had an intermediate survival between the two other groups (48.1%:
95% CI 44.3–51.8%). Again, there was no influence of patient age
or gender on the results.
Tumour perforation
In pT4 tumours those with perforation through the tumour had a
worse survival (26.4%: 95% CI 19.9–33.2%) than those with no
perforation (32.3%: 95% CI 26.0–38.9%) although this did not
reach statistical significance due to low reporting rates of just
Table 2 Hazard ratios for each pathological feature assessed adjusted for
age and gender
Characteristics
Hazard
ratio
Lower
95% CI
Upper
95% CI P-value
Local invasion T1 1.00
T2 1.22 0.97 1.53 0.09
T3 2.10 1.71 2.58 o0.01
T4 4.35 3.53 5.36 o0.01
Unknown 1.92 1.24 2.98 o0.01
N stage N0 1.00
N1 1.77 1.64 1.91 o0.01
N2 3.22 2.95 3.51 o0.01
Unknown 1.57 1.31 1.88 o0.01
Extramural vascular
invasion
Present 1.00
Absent 0.41 0.37 0.44 o0.01
Unknown 0.55 0.50 0.60 o0.01
Peritoneal involvement Present 1.00
Absent 0.42 0.39 0.45 o0.01
Unknown 0.52 0.46 0.59 o0.01
Tumour perforation Present 1.00
Absent 0.44 0.36 0.53 o0.01
Unknown 0.56 0.47 0.67 o0.01
Distance of invasion
beyond the muscularis
propria (T3’s only)(mm)
0–1mm 1.00
1.1–5 0.67 0.58 0.77 o0.01
5.1–10 0.83 0.73 0.94 o0.01
10.1–15 1.03 0.89 1.20 0.67
415 1.24 1.02 1.50 0.03
Unknown 1.43 1.19 1.72 o0.01
CRM status Involved 1.00
Uninvolved 0.43 0.37 0.51 o0.01
Unknown 0.51 0.41 0.63 o0.01
Number of nodes
examined
0–6 1.00
7–12 0.95 0.88 1.03 0.21
412 0.85 0.79 0.93 o0.01
Unknown 1.27 0.96 1.67 0.09
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Figure 1 Kaplan–Meier survival curves of the colorectal cancer
population by pathological T stage.
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s25.8% of this factor in pT4 tumours. Adjustment for age and
gender had no impact on the results (Table 2).
Distance of invasion beyond muscularis propria
Increasing distance of invasion beyond the muscularis propria in
pT3 tumours was associated with decreasing survival (Figure 5)
independently of the age and gender structure of the population
(Table 2). Patients who had a distance of invasion of less than 1
mm had a five-year survival of 60.8% (95% CI 57.0–64.3%)
compared to 36.9% (95% CI 30.5–43.4%) for those who had a
depth of invasion greater than 15 mm. Patients in whom this
feature was not reported had intermediate survival at 47.5% (95%
CI 43.8–51.2%).
Circumferential resection margin involvement
The survival of rectal cancer patients with an involved CRM, as
defined by the tumour lying less than one mm from the CRM,
was significantly worse (26.9%: 95% CI 21.7–32.4%) than patients
in whom this margin was clear (59.2%: 95% CI 56.4–
61.9%)(Po0.01). Patients for whom this feature was not reported
again had an intermediate survival of 52.7% (95% CI 46.2–58.9%).
These data are presented in Figure 6. Age and gender had no effect
on the trends seen (Table 2).
Distance to circumferential resection margin
Patients in whom the distance of the tumour from the
circumferential resection margin was less than 1 mm had
significantly poorer survival (33.3%: 95% CI 27.1–39.6%) than
those in whom the distance was greater than a millimetre
(Po0.01). Survival at 2mm was 52.4% (95% CI 44.0–60.0%).
There was no strong trend from improved survival when patients
were grouped according to increasing millimetre increments of
distance to the circumferential resection margin (Table 1).
Quality of reporting
As the total number of lymph nodes retrieved had been found to
relate to survival the relationship of this factor to reporting rates of
other factors was investigated (Table 3). Increasing total numbers
of lymph nodes retrieved from 0 to 6 to over 12 was found to be
positively correlated with detection of peritoneal involvement
(Po0.01) and EMVI (Po0.01) in all cases and CRM involvement
in rectal cases (Po0.01).
DISCUSSION
This study provides the first evidence from a population-based
setting to demonstrate that all the variables within the Royal
College of Pathologists colorectal cancer minimum dataset have
prognostic significance. Other variables currently not included
within the minimum dataset, such as increasing distance of
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Figure 2 Kaplan–Meier survival curves of the colorectal cancer
population by pathological N stage.
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Figure 3 Kaplan–Meier survival curves for the colorectal cancer
population by presence or absence of extramural vascular invasion (EMVI).
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Figure 4 Kaplan–Meier survival curves for the colorectal cancer
population by presence or absence of peritoneal involvement (PI).
0−1 mm 1.1−5 mm 5.1−10 mm 10.1−15 mm
over 15 mm unknown
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
0 0.5 1 1.5 2 2.5 3 3.5 4 4.5 5
Years
S
u
r
v
i
v
a
l
 
p
r
o
b
a
b
i
l
i
t
y
Figure 5 Kaplan–Meier curves for the colorectal cancer population by
distance of invasion beyond the muscularis propria.
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sinvasion beyond the muscularis propria in pT3 and pT4 tumours
were also found to be related to decreasing survival.
Local invasion, lymph node status, peritoneal involvement
and vascular invasion
The prognostic significance of local invasion, lymph node status
and lymph node yields (Pocard et al, 1998; Wong et al, 1999;
Tepper et al, 2001; Cserni et al, 2002; Goldstein, 2002; Johnson
et al, 2002; Prandi et al, 2002; Joseph et al, 2003; Pheby et al, 2004;
Baxter et al, 2005; Jestin et al, 2005; Sarli et al, 2005), peritoneal
involvement, tumour perforation and vascular invasion (Talbot
et al, 1980; Shepherd et al, 1989; Shepherd et al, 1995; Shepherd
et al, 1997; Petersen et al, 2002) have all previously been
documented. The results of this study confirm these findings in
a large population-based setting.
Circumferential resection margins
The negative survival impact of CRM involvement has also been
widely documented and our results support this previous work
(Quirke et al, 1986; Adam et al, 1994; Birbeck et al, 2002; Wibe
et al, 2002), but, the survival analyses looking at the distance to the
circumferential resection margin in millimetre intervals indicated
that there was a small and steady decrease in survival as this
distance narrows. The most pronounced fall was at the one
millimetre or less mark, with tumours lying between one and two
millimetres from the CRM behaving similarly to those lying two to
three millimetres away. This supports the work of Quirke et al
(1986) and subsequent studies (Birbeck et al, 2002) but appears to
contradict the more recent evidence and recommendations from
the Dutch TME trial by Nagtegaal et al (2002).
Distance of invasion beyond the muscularis propria
This study also validates the prognostic significance of distance of
invasion of tumour beyond the muscularis propria, supporting its
inclusion in the revised sixth edition of TNM classification
(American Joint Committee on Cancer, 2002). This data item is
not currently included in the Royal College’s minimum dataset but
the results of our work indicate it should be included in any future
revisions.
Quality of reporting
Patients in whom specific variables were not reported appear to
have an intermediate survival between those who possessed the
factor and those who did not. This suggests that absence of
reporting does not necessarily mean absence of the factor. In
addition, even where variables were definitely reported EMVI was
only found in 17.8% of cases and peritoneal involvement in 19.5%
of cases. Work from the CLASICC randomised controlled trial
suggest that when reported by those with a specialist interest in
gastro-intestinal pathology EMVI rates of 30% are seen. This is
important as the presence of some of these pathological factors
would influence an oncologist to offer adjuvant treatment. If an
oncologist is not aware that a patient is potentially at risk then
indicated treatment could be withheld with a concomitant increase
in the risk of death. This emphasises the importance of
comprehensive reporting of the minimum dataset. Previous work
has highlighted problems of inadequate reporting (Bull et al, 1997)
and our results demonstrate that failure to record key items is
associated with poorer outcomes. The absence of a factor on a
proforma does not equate with the prognosis of those in whom it
was recorded as being absent, suggesting that in a proportion of
patients it was indeed present. This was seen for EMVI, peritoneal
and CRM involvement. Additionally poor rates of positive
reporting of EMVI, peritoneal and CRM involvement are
intimately linked to a lower number of nodes found within the
NYCRIS data. Proforma reporting has been shown to improve the
completeness of pathological reporting (Cross et al, 1998; Branston
et al, 2002) but our results indicate significant amounts of key
variables were still missing. We believe the use of computer
proformas in which all data items had to be completed before a
pathologist could finish a report and the careful auditing of
pathology reporting against standards is essential. In addition,
adequate time must be made available for pathologists to
undertake thorough pathological examinations of all colorectal
cancer specimens. This would improve the quality of pathological
information, access of patients to adjuvant therapy and would be a
good investment for cancer care.
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Table 3 Rate of reporting of peritoneal and circumferential resection
margin involvement and extramural vascular invasion by total number of
lymph nodes retrieved in the study population
Number of nodes examined
0–6 7–12 412 Unknown
Characteristics n % n % n % n %
Peritoneal involvement Yes 304 26.2 417 35.9 426 36.7 13 1.1
No 1295 31.5 1536 37.4 1245 30.3 35 0.9
Unknown 193 28.6 265 39.2 185 27.4 33 4.9
EMVI Yes 215 20.3 390 36.8 450 42.4 6 0.6
No 804 25.6 1221 38.9 1099 35.0 15 0.5
Unknown 773 44.2 607 34.7 307 17.6 60 3.4
CRM (rectal cases only) Yes 66 25.4 91 35.0 99 38.1 4 1.5
No 374 31.1 456 37.9 362 30.1 11 0.9
Unknown 98 41.4 69 29.1 54 22.8 16 6.8
CRM uninvolved CRM involved unknown
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Figure 6 Kaplan–Meier curves for the rectal cancer population by
involvement of circumferential resection margin.
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